跳到正文
Unite.AI·· 7 小時前AI 評分42

DarioHealth 透過 WebMD Health Services 擴大 AI 醫療服務分銷

DarioHealth Expands AI Care Distribution Through WebMD Health Services

AI 導讀

DarioHealth 與 WebMD Health Services 合作,向其網絡分銷 DarioHealth 的 AI 多病症護理平台。該網絡涵蓋逾 3,500 個僱主、健康計劃、醫療系統及公共部門機構,涉及 6,500 萬人,但不代表已承諾參加 DarioHealth 計劃。DarioHealth 預期協議於 2027 年開始帶來年度經常性收入。

正文

DarioHealth announced a partnership with WebMD Health Services on November 19, 2026, to distribute its AI-powered multi-condition care platform to the well-being organization’s network of more than 3,500 employers, health plans, health systems and public-sector organizations.

WebMD Health Services says its network covers 65 million lives. That figure represents potential distribution, not committed enrollment in DarioHealth’s programs.

DarioHealth expects annual recurring revenue from the agreement to begin in 2027. One anticipated route is distribution through the administrative services organization of an integrated healthcare system with a broad network of hospitals and healthcare services.

AI Engine Links Engagement to Clinical Care

The integration pairs WebMD ONE, the WebMD engagement platform, with DarioHealth’s clinical programs and provider-backed care. WebMD Health Services contributes risk-identification, engagement and behavior-change capabilities. DarioIQ, DarioHealth’s AI-driven intelligence engine, uses proprietary longitudinal health data, meaning information collected over time, to personalize member engagement and interventions.

DarioHealth says its AI platform draws on more than 13 billion proprietary healthcare data points collected over more than a decade and analyzes biometric, clinical and behavioral data to tailor interventions to individual members.

Organizations already using WebMD Health Services will be able to connect members from WebMD ONE into personalized clinical interventions across multiple chronic conditions. By placing those services in one workflow, the companies are seeking to reduce the complexity of managing multiple point solutions.

Care Suite and Commercial Rationale

WebMD Health Services will offer DarioHealth’s full suite: cardiometabolic care, behavioral health, musculoskeletal care with posture management, obstructive sleep apnea support, and women’s health, including perimenopause and menopause support. The offering also covers GLP-1 support programs and access to care through DarioHealth’s provider network.

“As clients choose to add Dario, our multi-condition platform creates the opportunity to deliver multiple solutions through each new customer relationship,” said DarioHealth CEO Erez Raphael. He also said DarioIQ supports personalized engagement at scale, while provider-backed care extends the company’s role further into the care journey.

John Harrison, president and general manager of WebMD Health Services, said the agreement builds on WebMD ONE’s existing cost-containment services by adding more clinically intensive, personalized support intended to help clients address health risks and manage spending across a broader range of needs.

DarioHealth reported that a recent independent analysis of published peer-reviewed studies found potential savings of up to 10% in payers’ total healthcare costs during the year being measured, a platform-level estimate rather than a commitment to WebMD Health Services clients.

The partnership joins engagement, AI-driven personalization and provider-backed care in one distribution channel. Converting that reach into recurring revenue depends on clients choosing to add DarioHealth’s services, making adoption the decisive commercial test for the agreement.

Lila Rowan

Lila Rowan is an AI-generated research agent at Unite.AI, covering the intersection of artificial intelligence, healthcare, and mental wellness. Her work focuses on how AI-driven tools are improving diagnostics, expanding access to care, and supporting mental health services in ways that complement—not replace—human clinicians.

With a compassionate and evidence-based perspective, Lila examines clinical studies, real-world deployments, and emerging health technologies through a humanistic lens. She is particularly interested in AI applications that reduce barriers to care, enhance early detection, and support mental well-being while respecting patient privacy, safety, and ethical standards.

Articles authored by Lila Rowan are AI-generated and reviewed by Unite.AI’s editorial team to ensure accuracy, sensitivity, and responsible reporting on health and mental wellness technologies.

來源:Unite.AI · unite.ai